The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer

Hideya Takeuchi, Miyuki Abe, Yohei Takumi, Takafumi Hashimoto, Ryoji Kobayashi, Atsushi Osoegawa, Michiyo Miyawaki, Tatsuro Okamoto, Kenji Sugio

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Activated platelets promote tumor cell growth, angiogenesis, and invasion. Platelet activity can be inferred by platelet volume indices (PVIs), which include platelet distribution width (PDW), mean platelet volume (MPV), platelet distribution width-to-platelet count ratio (PDW/P), and mean platelet volume-to-platelet count ratio. Platelets and platelet-related markers, such as the platelet-to-lymphocyte ratio, have been found to be significant prognostic factors in patients with breast cancer. However, the role of PVIs for predicting survival in breast cancer remains unknown; hence, we performed this retrospective analysis of 275 patients with breast cancer. PVIs were compared with clinicopathological variables, and were assessed to identify independent indicators associated with disease-free survival (DFS) using the Cox proportional hazards model. An elevated PDW/P significantly correlated with age and HER2 status. Univariate analysis revealed that elevated PDW, MPV, and PDW/P as well as tumor size, nuclear grade, and lymph node involvement were significantly associated with inferior DFS rates (tumor size: p<0.01; nuclear grade, lymph node involvement, PDW, MPV, and PDW/P: p<0.05). On multivariate analysis, a large tumor size and elevated PDW/P were significant prognostic factors for DFS, with hazard ratios of 3.24 (95% confidence interval [CI]: 1.24–8.47) and 2.99 (95% CI: 1.18–7.57), respectively (p<0.05). Our study is the first to reveal that an elevated PDW/P significantly reduces DFS in patients with breast carcinoma. Measuring the PDW/P is simple, relatively inexpensive, and almost universally available using routine blood counts; this makes it an attractive biomarker for improved risk assessment.

Original languageEnglish
Article numbere0189166
JournalPloS one
Volume12
Issue number12
DOIs
Publication statusPublished - Dec 2017

Fingerprint

blood platelet count
Platelets
Platelet Count
breast neoplasms
Blood Platelets
Breast Neoplasms
Mean Platelet Volume
Disease-Free Survival
neoplasms
lymph nodes
confidence interval
Tumors
angiogenesis
Neoplasms
multivariate analysis
risk assessment
Lymph Nodes
cell growth
biomarkers
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer. / Takeuchi, Hideya; Abe, Miyuki; Takumi, Yohei; Hashimoto, Takafumi; Kobayashi, Ryoji; Osoegawa, Atsushi; Miyawaki, Michiyo; Okamoto, Tatsuro; Sugio, Kenji.

In: PloS one, Vol. 12, No. 12, e0189166, 12.2017.

Research output: Contribution to journalArticle

Takeuchi, H, Abe, M, Takumi, Y, Hashimoto, T, Kobayashi, R, Osoegawa, A, Miyawaki, M, Okamoto, T & Sugio, K 2017, 'The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer', PloS one, vol. 12, no. 12, e0189166. https://doi.org/10.1371/journal.pone.0189166
Takeuchi, Hideya ; Abe, Miyuki ; Takumi, Yohei ; Hashimoto, Takafumi ; Kobayashi, Ryoji ; Osoegawa, Atsushi ; Miyawaki, Michiyo ; Okamoto, Tatsuro ; Sugio, Kenji. / The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer. In: PloS one. 2017 ; Vol. 12, No. 12.
@article{bec9649e1cab40d487981a96f99c365d,
title = "The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer",
abstract = "Activated platelets promote tumor cell growth, angiogenesis, and invasion. Platelet activity can be inferred by platelet volume indices (PVIs), which include platelet distribution width (PDW), mean platelet volume (MPV), platelet distribution width-to-platelet count ratio (PDW/P), and mean platelet volume-to-platelet count ratio. Platelets and platelet-related markers, such as the platelet-to-lymphocyte ratio, have been found to be significant prognostic factors in patients with breast cancer. However, the role of PVIs for predicting survival in breast cancer remains unknown; hence, we performed this retrospective analysis of 275 patients with breast cancer. PVIs were compared with clinicopathological variables, and were assessed to identify independent indicators associated with disease-free survival (DFS) using the Cox proportional hazards model. An elevated PDW/P significantly correlated with age and HER2 status. Univariate analysis revealed that elevated PDW, MPV, and PDW/P as well as tumor size, nuclear grade, and lymph node involvement were significantly associated with inferior DFS rates (tumor size: p<0.01; nuclear grade, lymph node involvement, PDW, MPV, and PDW/P: p<0.05). On multivariate analysis, a large tumor size and elevated PDW/P were significant prognostic factors for DFS, with hazard ratios of 3.24 (95{\%} confidence interval [CI]: 1.24–8.47) and 2.99 (95{\%} CI: 1.18–7.57), respectively (p<0.05). Our study is the first to reveal that an elevated PDW/P significantly reduces DFS in patients with breast carcinoma. Measuring the PDW/P is simple, relatively inexpensive, and almost universally available using routine blood counts; this makes it an attractive biomarker for improved risk assessment.",
author = "Hideya Takeuchi and Miyuki Abe and Yohei Takumi and Takafumi Hashimoto and Ryoji Kobayashi and Atsushi Osoegawa and Michiyo Miyawaki and Tatsuro Okamoto and Kenji Sugio",
year = "2017",
month = "12",
doi = "10.1371/journal.pone.0189166",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer

AU - Takeuchi, Hideya

AU - Abe, Miyuki

AU - Takumi, Yohei

AU - Hashimoto, Takafumi

AU - Kobayashi, Ryoji

AU - Osoegawa, Atsushi

AU - Miyawaki, Michiyo

AU - Okamoto, Tatsuro

AU - Sugio, Kenji

PY - 2017/12

Y1 - 2017/12

N2 - Activated platelets promote tumor cell growth, angiogenesis, and invasion. Platelet activity can be inferred by platelet volume indices (PVIs), which include platelet distribution width (PDW), mean platelet volume (MPV), platelet distribution width-to-platelet count ratio (PDW/P), and mean platelet volume-to-platelet count ratio. Platelets and platelet-related markers, such as the platelet-to-lymphocyte ratio, have been found to be significant prognostic factors in patients with breast cancer. However, the role of PVIs for predicting survival in breast cancer remains unknown; hence, we performed this retrospective analysis of 275 patients with breast cancer. PVIs were compared with clinicopathological variables, and were assessed to identify independent indicators associated with disease-free survival (DFS) using the Cox proportional hazards model. An elevated PDW/P significantly correlated with age and HER2 status. Univariate analysis revealed that elevated PDW, MPV, and PDW/P as well as tumor size, nuclear grade, and lymph node involvement were significantly associated with inferior DFS rates (tumor size: p<0.01; nuclear grade, lymph node involvement, PDW, MPV, and PDW/P: p<0.05). On multivariate analysis, a large tumor size and elevated PDW/P were significant prognostic factors for DFS, with hazard ratios of 3.24 (95% confidence interval [CI]: 1.24–8.47) and 2.99 (95% CI: 1.18–7.57), respectively (p<0.05). Our study is the first to reveal that an elevated PDW/P significantly reduces DFS in patients with breast carcinoma. Measuring the PDW/P is simple, relatively inexpensive, and almost universally available using routine blood counts; this makes it an attractive biomarker for improved risk assessment.

AB - Activated platelets promote tumor cell growth, angiogenesis, and invasion. Platelet activity can be inferred by platelet volume indices (PVIs), which include platelet distribution width (PDW), mean platelet volume (MPV), platelet distribution width-to-platelet count ratio (PDW/P), and mean platelet volume-to-platelet count ratio. Platelets and platelet-related markers, such as the platelet-to-lymphocyte ratio, have been found to be significant prognostic factors in patients with breast cancer. However, the role of PVIs for predicting survival in breast cancer remains unknown; hence, we performed this retrospective analysis of 275 patients with breast cancer. PVIs were compared with clinicopathological variables, and were assessed to identify independent indicators associated with disease-free survival (DFS) using the Cox proportional hazards model. An elevated PDW/P significantly correlated with age and HER2 status. Univariate analysis revealed that elevated PDW, MPV, and PDW/P as well as tumor size, nuclear grade, and lymph node involvement were significantly associated with inferior DFS rates (tumor size: p<0.01; nuclear grade, lymph node involvement, PDW, MPV, and PDW/P: p<0.05). On multivariate analysis, a large tumor size and elevated PDW/P were significant prognostic factors for DFS, with hazard ratios of 3.24 (95% confidence interval [CI]: 1.24–8.47) and 2.99 (95% CI: 1.18–7.57), respectively (p<0.05). Our study is the first to reveal that an elevated PDW/P significantly reduces DFS in patients with breast carcinoma. Measuring the PDW/P is simple, relatively inexpensive, and almost universally available using routine blood counts; this makes it an attractive biomarker for improved risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=85037634974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037634974&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0189166

DO - 10.1371/journal.pone.0189166

M3 - Article

C2 - 29216259

AN - SCOPUS:85037634974

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e0189166

ER -